IxpressGenes
iXpressGenes is a privately held, Huntsville-based biotech tools company (founded 2006, 1-10 employees) that operates a web platform for molecular synthesis interfaces, protein expression data management, and automated laboratory inquiry workflows serving biotech researchers.
- Company typePrivate
- Founded2006
- HeadquartersHuntsville, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What IxpressGenes does
iXpressGenes is a privately held, for-profit biotechnology tools company headquartered in Huntsville, United States, founded in 2006. The company engages in protein crystallization, specialty enzymes, and contract research associated with genetic markets, and operates a web-based platform described as a high-performance interface for molecular synthesis, protein expression data management, and automated laboratory inquiry workflows serving the biotech research vertical. The platform consists of a core interface and associated modules: Qr1 (a distinct product component), Qr Survey, and Ymca Survey (data collection and inquiry tools), together with standard user account management features such as login, registration, and settings.
The company is led by CEO John Schmitt, the only disclosed member of the management team, and operates with 1-10 employees. The website is functional but minimal, presenting only login, registration, and standard policy pages, with no marketing content, no customer case studies, and no disclosed pricing. No patents, certifications, partnerships, customer logos, or revenue figures are publicly disclosed, representing significant data gaps for a diligence perspective.
iXpressGenes has raised a single disclosed funding round of $2,370,000 on 2025-06-25, with investors undisclosed. The combination of a 20-year operating history, a very small employee base, a minimal web presence, and the absence of disclosed commercial traction, ownership structure, or strategic partnerships characterizes the company as a small, opaque, vertically specialized biotech tooling operation with limited observable scale.
IxpressGenes firmographics
Firmographics- Name
- IxpressGenes
- Legal name
- iXpressGenes
- Website
- https://ixpressgenes.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- iXpressGenes is a privately held, Huntsville-based biotech tools company (founded 2006, 1-10 employees) that operates a web platform for molecular synthesis interfaces, protein expression data management, and automated laboratory inquiry workflows serving biotech researchers.
- Ownership category
- akta.pro rank
IxpressGenes industry classification
Industry- Product category
- Biotech Contract Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC)
- akta.pro secondary industries
- mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC), Recombinant Protein Therapeutics (enzymes, hormones, growth factors) (HLAAAAAB)
Keywords
Where IxpressGenes is headquartered
LocationHeadquarters
- HQ city
- Huntsville
- HQ country
- United States
- HQ region
- North America
Markets served
IxpressGenes business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain
IxpressGenes product offering
Product offeringCore offering
IxpressGenes provides protein crystallization services, specialty enzymes, and contract research for biotech/genetic markets. The company operates a web-based platform that delivers a high-performance interface for molecular synthesis, protein expression data management, and automated laboratory inquiry workflows targeted at biotech researchers.
Product overview
iXpressGenes is a unified platform providing a high-performance interface for molecular synthesis, protein expression data management, and automated laboratory inquiry workflows for biotech research. The platform consists of a core interface with associated modules including Qr1 (a distinct product component), Ymca Survey, and Qr Survey (survey tools for data collection and inquiry workflows), along with standard user account management features (Login, Register, Settings, Password Reset).
Differentiator
Problem solved
Functional benefit
Products and services
- Protein Crystallization Services
- Specialty Enzymes Specialty enzyme products supplied to biotech and genetic research customers as reagents for molecular biology and protein research workflows.
- Contract Research Services Contract research services delivered to biotech and genetic research customers, accessed through the iXpressGenes platform that provides molecular synthesis, protein expression data management, and automated laboratory inquiry workflows.
- iXpressGenes Platform (Molecular Synthesis & Protein Expression Interface) An online platform providing a high-performance interface for molecular synthesis, protein expression data management, and automated laboratory inquiry workflows for biotech research customers, with supporting modules such as Qr1, Ymca Survey, and Qr Survey.
Companies that use IxpressGenes
Customer profileSegments1 record
Ideal customer profiles1 record
IxpressGenes technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
IxpressGenes partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights1 record
IxpressGenes competitors and assessment
Company assessmentEmerging players
- Codexis: Applies protein engineering and directed evolution to develop specialty enzymes — overlapping with the protein engineering / specialty enzyme space iXpressGenes operates in.
- ProteoGenix: Offers protein expression, antibody production, and related contract services — overlapping with the protein expression and contract research capabilities of iXpressGenes.
- Creative Enzymes: Specialty enzyme supplier focused on research and industrial applications — comparable niche positioning to iXpressGenes' specialty enzyme line.
Direct peers
- GenScript: Provides gene synthesis, protein expression, and related contract research services to biotech customers — directly overlapping with iXpressGenes' molecular synthesis and protein expression offering.
- ATUM (formerly DNA2.0): Offers gene synthesis, protein engineering, and contract research services for biotech, directly comparable to the molecular synthesis and protein expression capabilities of iXpressGenes.
- New England Biolabs: A leading specialty enzyme manufacturer serving molecular biology and protein research markets, closely aligned with iXpressGenes' specialty enzymes focus.
- Worthington Biochemical: Specialty enzyme and protein reagent supplier with a long operating history, comparable in scale and product orientation to iXpressGenes.
Broad incumbents
- Promega Corporation: Broad life science tools provider with enzymes, protein reagents, and contract services — a larger incumbent competing in many of the same workflows.
- Bio-Techne: Diversified life science reagents and tools company with a substantial protein and enzyme portfolio — a broad incumbent competing for the same biotech research customers.
- Thermo Fisher Scientific: The largest life science tools and CRO provider globally, with deep coverage across enzymes, protein reagents, and contract research services.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat2 records
Key risks5 records
Key highlights3 records
Customer concentration
IxpressGenes social profiles
Digital presenceIxpressGenes financial estimates
Financial estimateRevenue estimate
Valuation estimate
IxpressGenes leadership team
Management profileNumber of profiles
Profiles1 record
IxpressGenes funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IxpressGenes M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IxpressGenes
What does IxpressGenes do?
IxpressGenes provides protein crystallization services, specialty enzymes, and contract research for biotech/genetic markets. The company operates a web-based platform that delivers a high-performance interface for molecular synthesis, protein expression data management, and automated laboratory inquiry workflows targeted at biotech researchers.
Is IxpressGenes a public or private company?
IxpressGenes is a private company. It is classified as unknown and is currently operating.
When was IxpressGenes founded?
IxpressGenes was founded in 2006. It employs 11 to 50 people.
Where is IxpressGenes based?
IxpressGenes is headquartered in Huntsville, United States, in the North America region.
Who are IxpressGenes's main competitors?
Emerging players on record are Codexis, ProteoGenix and Creative Enzymes. Direct peers are GenScript, ATUM (formerly DNA2.0), New England Biolabs and Worthington Biochemical. Broad incumbents are Promega Corporation, Bio-Techne and Thermo Fisher Scientific.
Does IxpressGenes have an API?
No public API is recorded for IxpressGenes.
What industry is IxpressGenes in?
IxpressGenes's product category is Biotech Contract Research Services. Its primary akta.pro industry code is HLAAAIAC, Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization), with a secondary code of HLAGAGAC, mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA). Its NAICS code is 541714 and its SIC code is 8731.